Detailed information for compound 1270196

Basic information

Technical information
  • TDR Targets ID: 1270196
  • Name: N-[1-(4-bromophenyl)-3-oxo-3-pyrrolidin-1-ylp rop-1-en-2-yl]-2-fluorobenzamide
  • MW: 417.272 | Formula: C20H18BrFN2O2
  • H donors: 1 H acceptors: 2 LogP: 4.13 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Brc1ccc(cc1)/C=C(\C(=O)N1CCCC1)/NC(=O)c1ccccc1F
  • InChi: 1S/C20H18BrFN2O2/c21-15-9-7-14(8-10-15)13-18(20(26)24-11-3-4-12-24)23-19(25)16-5-1-2-6-17(16)22/h1-2,5-10,13H,3-4,11-12H2,(H,23,25)/b18-13+
  • InChiKey: MRWIXRGKPDWRDG-QGOAFFKASA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[(E)-1-(4-bromophenyl)-3-oxo-3-pyrrolidin-1-ylprop-1-en-2-yl]-2-fluorobenzamide
  • N-[2-(4-bromophenyl)-1-(pyrrolidine-1-carbonyl)vinyl]-2-fluoro-benzamide
  • N-[(E)-2-(4-bromophenyl)-1-(pyrrolidine-1-carbonyl)vinyl]-2-fluoro-benzamide
  • N-[2-(4-bromophenyl)-1-(oxo-1-pyrrolidinylmethyl)vinyl]-2-fluorobenzamide
  • N-[(E)-2-(4-bromophenyl)-1-(oxo-1-pyrrolidinylmethyl)vinyl]-2-fluorobenzamide
  • N-[1-(4-bromophenyl)-3-oxo-3-pyrrolidin-1-yl-prop-1-en-2-yl]-2-fluoro-benzamide
  • N-[(E)-1-(4-bromophenyl)-3-oxo-3-pyrrolidin-1-yl-prop-1-en-2-yl]-2-fluoro-benzamide
  • 6063-65-6
  • BIM-0043414.P001
  • MLS000701360
  • N-[2-(4-bromophenyl)-1-(1-pyrrolidinylcarbonyl)vinyl]-2-fluorobenzamide
  • SMR000225080
  • ZINC00715769
  • AE-848/14270022
  • CBMicro_043269

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens RAB9A, member RAS oncogene family Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum ras-related protein Rab-5B RAB9A, member RAS oncogene family 201 aa 165 aa 30.9 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0506 0.126 0.6526
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0506 0.126 0.3671
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0422 0.0889 0.2537
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0975 0.3331 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Loa Loa (eye worm) hypothetical protein 0.0318 0.043 0.2526
Loa Loa (eye worm) phosphatidylinositol 3 0.0606 0.1702 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Echinococcus multilocularis serine protein kinase ATM 0.0422 0.0889 0.0889
Trichomonas vaginalis PIKK family atypical protein kinase 0.0285 0.0286 0.168
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0506 0.126 0.3671
Giardia lamblia GTOR 0.0506 0.126 0.5
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0506 0.126 0.6526
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0285 0.0286 0.168
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0975 0.3331 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Leishmania major phosphatidylinositol 3-kinase, putative 0.0506 0.126 0.3831
Entamoeba histolytica Phosphatidylinositol 3- and 4-kinase family 0.0385 0.0728 0.4536
Trypanosoma brucei phosphatidylinositol kinase related protein, putative 0.0422 0.0889 0.3608
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit 0.2485 1 1
Echinococcus granulosus serine protein kinase ATM 0.0422 0.0889 0.0889
Toxoplasma gondii target of rapamycin (TOR), putative 0.0506 0.126 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Leishmania major hypothetical protein, conserved 0.0944 0.3194 1
Trypanosoma cruzi target of rapamycin kinase 3 0.0506 0.126 0.3671
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0422 0.0889 0.5222
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0506 0.126 0.3831
Echinococcus granulosus serine:threonine protein kinase SMG1 0.0285 0.0286 0.0286
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0506 0.126 0.6526
Schistosoma mansoni fkbp-rapamycin associated protein 0.0285 0.0286 0.0858
Trichomonas vaginalis PIKK family atypical protein kinase 0.0285 0.0286 0.168
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0285 0.0286 0.0858
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Loa Loa (eye worm) hypothetical protein 0.0285 0.0286 0.168
Trypanosoma cruzi phosphatidylinositol 3-kinase, putative 0.0285 0.0286 0.0695
Trichomonas vaginalis PIKK family atypical protein kinase 0.0285 0.0286 0.168
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0506 0.126 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0285 0.0286 0.168
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0285 0.0286 0.168
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0506 0.126 0.3783
Trichomonas vaginalis conserved hypothetical protein 0.0318 0.043 0.2526
Loa Loa (eye worm) phosphatidylinositol 3 0.0506 0.126 0.7404
Loa Loa (eye worm) hypothetical protein 0.0324 0.0459 0.2697
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0506 0.126 0.126
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0975 0.3331 0.3331
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0506 0.126 0.3783
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0606 0.1702 1
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.0606 0.1702 1
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0975 0.3331 1
Trypanosoma cruzi hypothetical protein, conserved 0.0847 0.2764 0.8269
Toxoplasma gondii FATC domain-containing protein 0.0422 0.0889 0.5528
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0506 0.126 0.6526
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0385 0.0728 0.4276
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0975 0.3331 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Leishmania major phosphatidylinositol 3-related kinase, putative 0.0606 0.1702 0.524
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0422 0.0889 0.2668
Trichomonas vaginalis PIKK family atypical protein kinase 0.0318 0.043 0.2526
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0506 0.126 1
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0324 0.0459 0.1223
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0975 0.3331 0.3331
Schistosoma mansoni ataxia telangiectasia mutated (atm) 0.0422 0.0889 0.2668
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0506 0.126 0.126
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.0506 0.126 0.3831
Echinococcus multilocularis serine:threonine protein kinase SMG1 0.0285 0.0286 0.0286
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Entamoeba histolytica hypothetical protein 0.0422 0.0889 0.6189
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0506 0.126 0.3831
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404
Trichomonas vaginalis PIKK family atypical protein kinase 0.0506 0.126 0.7404

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) = 1.2589 um PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.